Implantica publishes Interim Report Q1, January – March 2022
SUCCESSFUL REFLUXSTOP™ MARKET ACCESS STRATEGYImplantica publishes Interim Report Q1, January – March 2022 SUCCESSFUL REFLUXSTOP™ MARKET ACCESS STRATEGY Significant events in the first quarter of 2022 · Implantica continued during this quarter to substantially strengthen its organisation on a broad front. Since our vision is to become the world leader in smart medical implants, we embrace the fact that the talent and calibre of our people are fundamental to achieve this goal. This shared vision has attracted world-class talent from diverse leading organizations.